US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)

22.50

+2.1910.78%

Volume:3.33K

Turnover:74.51K

Market Cap:2.53B

PE:-11.14

High:22.50

Open:22.00

Low:22.00

Close:20.31

52wk High:29.99

52wk Low:5.45

Shares:112.63M

Float Shares:112.63M

Volume Ratio:4.22

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0190

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.newamsterdampharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NAMSW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"NAMSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)","latestPrice":22.5,"timestamp":1770670800000,"preClose":20.31,"halted":0,"volume":3326,"delay":0,"changeRate":0.10782865583456433,"floatShares":112628458,"shares":112628458,"eps":-2.019,"marketStatus":"Not Yet Opened","change":2.19,"latestTime":"02-09 16:00:00 EST","open":22,"high":22.5,"low":22,"amount":74508.23,"amplitude":0.024618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.019,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":20.31,"volumeRatio":4.221884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","floatShares":112628458,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.221884,"shares":112628458,"dividePrice":0,"high":22.5,"amplitude":0.024618,"preClose":20.31,"low":22,"week52Low":5.45,"pbRate":"--","week52High":29.99,"institutionHeld":0,"latestPrice":22.5,"eps":-2.019,"divideRate":0,"volume":3326,"delay":0,"ttmEps":-2.019,"open":22,"prevYearClose":23,"prevWeekClose":20.31,"prevMonthClose":19.45,"prevQuarterClose":23,"fiveDayClose":20,"twentyDayClose":23.95,"sixtyDayClose":28.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMSW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMSW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.newamsterdampharma.com","stockEarnings":[{"period":"1week","weight":0.125},{"period":"1month","weight":-0.0605},{"period":"3month","weight":-0.2055},{"period":"6month","weight":0.5901},{"period":"1year","weight":1.2523},{"period":"ytd","weight":-0.0217}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.536633},{"month":2,"riseRate":0.6,"avgChangeRate":0.054027},{"month":3,"riseRate":0.2,"avgChangeRate":-0.24039},{"month":4,"riseRate":0.8,"avgChangeRate":0.178974},{"month":5,"riseRate":0,"avgChangeRate":-0.269123},{"month":6,"riseRate":0.6,"avgChangeRate":-0.001234},{"month":7,"riseRate":0.4,"avgChangeRate":1.643099},{"month":8,"riseRate":0.6,"avgChangeRate":-0.000678},{"month":9,"riseRate":0.4,"avgChangeRate":0.030454},{"month":10,"riseRate":0.8,"avgChangeRate":0.20425},{"month":11,"riseRate":0.8,"avgChangeRate":0.092319},{"month":12,"riseRate":0.6,"avgChangeRate":0.101716}],"exchange":"NASDAQ","name":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)","nameEN":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NAMSW\",market:\"US\",,,undefined,":null}}